Corpus Intelligence IC Memo — BEAR VALLEY COMMUNITY HOSPITAL 2026-04-26 15:42 UTC
IC Memo — BEAR VALLEY COMMUNITY HOSPITAL
Investment Committee Memorandum | CA | 9 beds | Grade D | EBITDA uplift $2.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BEAR VALLEY COMMUNITY HOSPITAL

CCN 051335 | SAN BERNARDINO, CA | 9 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

BEAR VALLEY COMMUNITY HOSPITAL is a 9-bed community hospital in SAN BERNARDINO, CA with $30.8M in net patient revenue and a -9.6% operating margin. The hospital serves a payer mix of 53.8% Medicare, 0.0% Medicaid, and 46.2% commercial.

Thesis: Turnaround. Our ML models identify $2.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -9.6% to -2.3% (+736bps).

Net Revenue HCRIS$30.8M
Current EBITDA COMPUTED$-3.0M
Operating Margin COMPUTED-9.6%
Occupancy HCRIS31.4%
Revenue / Bed COMPUTED$3.4M
Net-to-Gross HCRIS49.9%
Distress Probability MLnan%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
21
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -9.6% places it below the state median. Among 21 size-comparable peers (4-18 beds), the median margin is -10.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (4-18), prioritizing same-state peers. 21 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BEAR VALLEY COMMUNITY HOSPITAL (Target)CA9$30.8M-9.6%
PORTERVILLE DEVELOPMENTAL CENTCA17$193.6M-6.0%
SOUTHERN MONO HEALTH CARE DISTCA17$99.1M4.1%
JEWISH HOME FOR THE AGEDCA13$88.0M-48.0%
MEE MEMORIAL HOSPITALCA13$67.6M3.3%
JOYCE EISENBERG KEEFER MEDICALCA10$52.9M18.8%
MAYERS MEMORIAL HOSPITALCA16$41.7M-1.3%
WEST COVINA MEDICAL CENTERCA13$40.6M55.3%
MEE MEMORIAL HOSPITALCA13$36.3M-23.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$647K+210bp18mo
Cost to Collect4.5%2.5%$617K+200bp12mo
Denial Rate Reduction12.0%6.5%$610K+198bp12mo
A/R Days Reduction5200.0%3800.0%$375K+122bp9mo
Clean Claim Rate88.0%96.0%$20K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$647K
Cost to Collect
$617K
Denial Rate Reduction
$610K
A/R Days Reduction
$375K
Clean Claim Rate
$20K
Total EBITDA Uplift$2.3M
Current EBITDA$-3.0M
+ RCM Uplift+$2.3M
Pro Forma EBITDA$-703K
Current Margin-9.6%
Pro Forma Margin-2.3%
WC Released (1x)$1.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.6M$3.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.6M$1.9M0.00x-100.0%
Bull Case9.0x11.0x$-4.1M$7.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-4.1M$7.4M0.00x-100.0%
Bear Case11.0x10.0x$-5.0M$-6.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-5.0M$-9.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 31.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 21 hospitals with 4-18 beds
  • Same-state prioritization (n=27)
  • Comp margins: P25=-48.0% / P50=-10.2% / P75=3.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.